E-LIB Suche - Ergebnisse für: Pagnini, Cristiano

1

Colonic Epithelial Permeability to Ions Is Restored after V..:

Cicala, Michele ; Gori, Manuele ; Balestrieri, Paola...
International Journal of Molecular Sciences. 25 (2024) 11 - p. 5817 , 2024

Link: https://doi.org/10.3390/..

2

Safety and Potential Role of Lactobacillus rhamnosus GG Adm..:

Pagnini, Cristiano ; Di Paolo, Maria Carla ; Urgesi, Riccardo...
Microorganisms. 11 (2023) 6 - p. 1381 , 2023

Link: https://doi.org/10.3390/..

3

Application of validated bleeding risk scores for atrial fi..:

Urgesi, Riccardo ; Pagnini, Cristiano ; De Angelis, Fernando...
International Journal of Colorectal Disease. 38 (2023) 1 - p. , 2023

Link: https://doi.org/10.1007/..

4

Safety and Potential Role of Lactobacillus rhamnosus GG Adm..:

Cristiano Pagnini ; Maria Carla Di Paolo ; Riccardo Urgesi...
Gut Microbiota. , 2023

Link: https://doi.org/10.3390/..

5

Safety and Potential Role of Lactobacillus rhamnosus GG Adm..:

Cristiano Pagnini ; Maria Carla Di Paolo ; Riccardo Urgesi...
https://www.mdpi.com/2076-2607/11/6/1381. , 2023

Link: https://doi.org/10.3390/..

6

Safety and Potential Role of Lactobacillus rhamnosus GG Adm..:

Pagnini, Cristiano ; Di Paolo, Maria Carla ; Urgesi, Riccardo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304992/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Evaluation of Accuracy and Feasibility of a New-Generation ..:

Cagnoni, Marco ; Pagnini, Cristiano ; Crovaro, Marco...
Gastrointestinal Disorders. 4 (2022) 3 - p. 205-213 , 2022

Link: https://doi.org/10.3390/..

8

Replacement of Adalimumab Originator to Adalimumab Biosimil..:

Zampaletta, Costantino ; Armuzzi, Alessandro ; Turchini, Laura...
Journal of Gastrointestinal and Liver Diseases. 31 (2022) 4 - p. 411-416 , 2022

Link: https://doi.org/10.15403..

9

Adalimumab Biosimilar GP2017 versus Adalimumab Originator i..:

Mocci, Giammarco ; Bodini, Giorgia ; Allegretta, Leonardo...
Biomedicines. 10 (2022) 8 - p. 1799 , 2022

Link: https://doi.org/10.3390/..

10

Evaluation of Accuracy and Feasibility of a New-Generation ..:

Marco Cagnoni ; Cristiano Pagnini ; Marco Crovaro...
https://dx.doi.org/10.3390/gidisord4030019. , 2022

Link: https://doi.org/10.3390/..

11

Adalimumab Biosimilar GP2017 versus Adalimumab Originator i..:

Giammarco Mocci ; Giorgia Bodini ; Leonardo Allegretta...
https://www.mdpi.com/2227-9059/10/8/1799. , 2022

Link: https://doi.org/10.3390/..

12

Adalimumab Biosimilar GP2017 versus Adalimumab Originator i..:

Giammarco Mocci ; Giorgia Bodini ; Leonardo Allegretta...
Molecular and Translational Medicine. , 2022

Link: https://doi.org/10.3390/..

13

Adalimumab Biosimilar GP2017 versus Adalimumab Originator i..:

Mocci, Giammarco ; Bodini, Giorgia ; Allegretta, Leonardo...
info:eu-repo/semantics/altIdentifier/pmid/35892698. , 2022

Link: https://hdl.handle.net/2..

14

Adalimumab Biosimilar GP2017 versus Adalimumab Originator i..:

Mocci, Giammarco ; Bodini, Giorgia ; Allegretta, Leonardo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331541/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Evaluation of Accuracy and Feasibility of a New-Generation ..:

Marco Cagnoni ; Cristiano Pagnini ; Marco Crovaro...
https://www.mdpi.com/2624-5647/4/3/19. , 2022

Link: https://doi.org/10.3390/..